Reicin Glenn 4
4 · Sigilon Therapeutics, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
Reicin Glenn
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-11+55,000→ 55,000 totalExercise: $39.81Exp: 2031-02-10→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The option vest as to 25% of the underlying shares of common stock on February 11, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.